J&J COVID-19 vaccine benefits outweigh risks but some women may want to reconsider, doctor says

Former CDC Director Dr. Tom Frieden joins Weekend TODAY to discuss the Johnson & Johnson COVID-19 vaccine after the pause was lifted following reports of blood clots. “Yesterday’s deliberation proved very clear that the benefits far outweigh the risks for every group, but women who are under 50 may wish to receive the other vaccines,” he says.